Economic analysis demonstrates cost-effectiveness of hepatitis B screening in Vietnam, suggesting improved health outcomes.
A one-time universal screening is likely to be cost-effective under the current WTP threshold. Clinical impact would be increased if linkage to care and treatment rates were to be improved.
No takes yet. Share an insight, caveat, or question.
Horta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: